Logo

GSK's Advil Dual Action in Combination with Acetaminophen Receives the US FDA's Approval for Pain Relief

Share this

GSK's Advil Dual Action in Combination with Acetaminophen Receives the US FDA's Approval for Pain Relief

Shots:

  • The approval is based on seven clinical studies including three of which were pivotal efficacy and safety studies in pain relief which involves assessing of ibuprofen (250 mg) + acetaminophen (500 mg) vs ibuprofen and acetaminophen monothx in patients with acute pain symptoms
  • The study demonstrated that the FD combination achieved superior efficacy then the monotherapy in patients
  • Advil Dual Action is combination of ibuprofen and acetaminophen resulting to an exclusive pain reliever and will be available over-the-counter nationwide in 2020

Click here to read full press release/ article

Ref: PRNewswire | Image: GSK


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions